Rome III, a set of criteria used to diagnose functional GI disorders, describes the diagnosis of chronic constipation as constipation for at least six months as well as specific symptoms for at least three months (eg, straining with at least 25% of bowel movements, details here)
More than 70% of patients taking GLP-1 medications reported reduced alcohol cravings, a decreased desire to drink, a reduction in how much alcohol they drink per week, fewer drinks per drinking session, and reduced binge drinking compared to prior to starting treatment compared to the control group that was not taking GLP-1 medications
What are retatrutides side effects
In a well-nourished person, adding selenium does not push them higher
The effects of Saxenda on cardiovascular morbidity and mortality have not been established
Indirect benefits through weight loss are potentially more significant